|
|
| Research article summary (published 29 Sep 2009): |
Heartmate II axial-flow left ventricular assist system: management, clinical review and personal experience.
Full Abstract
OBJECTIVES: The excellent results with left ventricular assist devices (LVADs) have revolutionized the treatment options for end-stage heart failure. The use of pulsatile devices is associated with significant comorbidity and limited durability. The axial-flow HeartMate II LVAD represents the new generation of devices. The clinical use of this pump resulted in superior outcomes. We review the HeartMate II technology, management, clinical usage and our experience. METHODS: Between 3/2002 and 12/2008, 18 transplantable adult patients were supported on long-term HeartMate II LVAD at our institution (13 men, age 52 +/- 8.4 years, range: 31-64 years). Primary indications were: ischemic cardiomyopathy (CMP) (n = 13), idiopathic CMP (n = 5). All patients were in New York Heart Association (NYHA) Class IV heart failure. None of patients had prior open-heart surgery. Implantation via cannulation of the left ventricular apex and the ascending aorta was always elective. RESULTS: Mean support time was 217 +/- 212.3 days (range: 1-665 days). Early (30-day) mortality was 27.7% (five patients) with multiple organ failure and sepsis as main causes of death. Bleeding requiring reoperation occurred in six (33.3%) cases. Cerebral hemorrhage occurred in one patient. There were two driveline infections and no device failure. Twelve (66.6%) patients were successfully discharged home. Overall nine patients (50%) were transplanted and two patients are actually waiting for a suitable organ (n = 2 patients discharged home and n = 1 patient in hospital). At latest, follow-up survival rate after heart transplantation is 66.6% (six patients). CONCLUSION: Long-term HeartMate II LVAD provides good mid-term, long-term results. This new technology requires delicate management. Functional status and quality of life greatly improve in patients who survive the perioperative period.
Author information
Author/s: Loforte, Antonino (A); Montalto, Andrea (A); Ranocchi, Federico (F); Casali, Giovanni (G); Luzi, Giampaolo (G); Monica, Paola Lilla Della (PL); Sbaraglia, Fabio (F); Polizzi, Vincenzo (V); Distefano, Giada (G); Musumeci, Francesco (F);
Affiliation: Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Rome, Italy. antonioloforte(-atsign-)yahoo.it
Journal and publication information
Publication Type: Journal Article
Journal: Journal of cardiovascular medicine (Hagerstown, Md.) (J Cardiovasc Med (Hagerstown)), published in United States. (Language: eng)
Reference: 2009-Oct; vol 10 (issue 10) : pp 765-71
Dates: Created 2009/08/26; Completed 2009/10/15;
PMID: 19465866, status: MEDLINE (last retrieval date: 10/15/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Results of the first 100 patients who received Symbion Total Artificial Hearts as a bridge to cardiac transplantation.
30 Oct 1989 - Univentricular and biventricular Thoratec VAD support as a bridge to transplantation.
30 Dec 1992 - Mechanical bridge to transplantation with the Vienna heart in TAH and LVAD configuration.
28 Feb 1992 - [An evaluation of simultaneous application of IABP during ventricular assist device]
30 Dec 1986 - Hemopump left ventricular support in the peripartum cardiomyopathy patient.
30 Dec 1993 - HeartMate left ventricular assist device for long-term circulatory support.
30 Mar 2000 - Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators.
28 May 2006 - The need for the development of therapeutically combined artificial organs.
30 Aug 1997 - Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
4 Feb 2006 - Alterations in alpha adrenoreceptor density and localization after mechanical left ventricular unloading with the Jarvik flowmaker left ventricular assist device.
29 Apr 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.